Navigation Links
75 Percent of Hospital IT Leaders View Interoperability Between Vendor Systems as Critical to Operational Effectiveness in Healthcare Settings
Date:2/23/2011

MOUNTAIN VIEW, Calif., Feb. 23, 2011 /PRNewswire/ -- Omnicell, Inc., (Nasdaq: OMCL) a leading provider of medication management systems to healthcare facilities, today announced the results of a survey conducted at HIMSS 2011. 100 healthcare executives were polled to identify trends in requirements for vendor interoperability and factors motivating hospital IT purchasing decisions. The survey found that the majority of hospitals recognize the critical role interoperability plays in improving patient care.

The survey results identified the following trends as top concerns among hospital IT leaders attending HIMSS:

  • The interoperability of multiple vendor systems within a hospital's IT infrastructure is deemed critical to operational effectiveness by 75 percent of hospital IT leadership.
  • 38 percent of hospitals are changing the way they purchase, distribute and manage medication and supplies due to financial pressures.
  • When considering system maintenance, costs and patient care, 66 percent identified patient centered care as the most important criteria when investing in IT resources to improve systems-based interoperability within a facility.

"It is exciting to see that over 75 percent of hospital IT leadership identified that interoperability in a hospital's IT infrastructure is critical to hospital operational effectiveness," said Marga Ortigas-Wedekind, Omnicell vice president, global marketing and product development. "The interoperability of Omnicell solutions is demonstrated daily in over 1600 hospitals nationwide. These survey results reinforce Omnicell's ability to address hospital IT leadership concerns in a meaningful way."

Omnicell announced they are demonstrating interoperable standards-based technology solutions with their automated dispensing cabinets for medication management at the HIMSS11 Interoperability Showcase. The Showcase is part of the 2011 Annual HIMSS Conference and Exhibition and is held in collaboration with Integrating the Healthcare Enterprise (IHE). The Showcase is located in Hall E of the Orange County Convention Center in Orlando, Florida from February 20-24, 2011.

About Omnicell

Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of systems to enable healthcare facilities to increase operational efficiency, enhance patient safety and allow clinicians to spend more time with their patients.

Founded in 1992, Omnicell's medication-use solutions include complete automation systems for the central pharmacy, anesthesia workstations for the operating room, dispensing cabinet systems for nursing units, and safe, secure medication transportation and verification systems to the patient bedside. From a medication's arrival at the receiving dock to its dosing to the patient, Omnicell systems store it, package it, bar code it, order it, issue it, and provide information and controls on its use and reorder.  

Omnicell supply product lines provide a healthcare institution with comprehensive supply chain solutions that result in fast, effective control of costs, capture of charges for payer reimbursement, and timely reorder of supplies. Products range from high-security closed-cabinet systems and software to open-shelf and combination solutions in the nursing unit, cath lab, and operating room.

OMCL - G


'/>"/>
SOURCE Omnicell, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations
2. Hill-Rom Reports 77 Percent Growth in First Quarter Earnings Per Share
3. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
4. Groundbreaking Study Showed Bayers Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain
5. Shingles Vaccine Associated With 55 Percent Reduced Risk of Disease
6. Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available
7. On Average, 55 Percent of Surveyed U.S. Asthma Patients Say They Are Likely to Request a Switch to a Drug With Efficacy Comparable to Their Current Medication but Which is Dosed Just Once a Day
8. Sales of Revlimid and the Launch of Several Premium-Priced Emerging Therapies Will Drive Robust 7.2 Percent Annual Growth in the Multiple Myeloma Drug Market
9. ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute
10. Volcano Reports 35 Percent Increase in Third Quarter Revenues; Records $9.6 Million Improvement in Year-Over-Year GAAP Profitability
11. Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... held the largest share in the ECG Cables And ... demand for remote monitoring ECG devices. On the other hand, ... to witness the highest growth rate during the forecast period. ... Dickinson and Company (U.S.), Medtronic plc ( Ireland ... and Mindray Medical International Limited ( China ), ...
(Date:12/2/2016)... , Dec 2, 2016 Research and Markets ... Share, Development, Growth and Demand Forecast to 2022" report to their ... , , ... $6 billion in 2015, and it is expected to grow at a ... is expected to witness faster growth during the forecast period, a CAGR ...
(Date:12/2/2016)... SAN FRANCISCO , Dec. 2, 2016  PipelineRx, ... clinical telepharmacy, will be offering demonstrations of its ... American Society of Health-System Pharmacists 2016 Midyear Clinical ... Las Vegas . With nearly 300 hospital ... telepharmacy services and technology designed to dramatically improve ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... 2016 , ... On Dec. 2, 2016, CURE® magazine will host the 4th ... 2016 MPN Heroes—eight individuals who have made a difference in the field of rare ... of care, demonstrating leadership within the MPN community and/or a commitment to individual patients. ...
(Date:12/2/2016)... ... , ... Advanced Inc., a leading provider of travel therapy and travel nursing ... as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as ... operational leadership experience to Advanced Inc. He began his career in finance at Ernst ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to change ... Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch ... plan (Part D) need to make changes during this period order for their new ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s newest campaign, ... standing as living proof that attitude and determination can combine into the most ... spike around the holidays. This campaign will offer patients a new-found hope, by ...
(Date:12/2/2016)... ... 2016 , ... Mediaplanet is proud to announce the launch ... innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians ... years in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. ...
Breaking Medicine News(10 mins):